We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey.
𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:
Take part in shaping this community by sharing your feedback, questions or ideas. This you can do through our community page:
https://www.linkedin.com/groups/12717528/
Follow us:
Nehar: https://www.linkedin.com/in/neharmortuza/
and
Søren: https://www.linkedin.com/in/soren-spanner-bach/
Site
RSS
Apple
Data updated on 27/08/2026
Recent rankings
Latest chart positions across Apple Podcasts and Spotify rankings.
Shared links between episodes and podcasts
Links found in episode descriptions and other podcasts that share them.
Discover shows related to Life Science Talent Talks, based on actual content similarities. Explore podcasts with similar topics, themes, and formats, backed by real data.
E72 #Ecosystem Builders “From Lab to Value Chain: Mission-Driven Carbon Capture” with CORC's Lasse Rosendahl & Alexia Jacobsen
Episode 72
Thursday, August 20, 2026 • Duration 53:53
In this podcast episode on turning research into societal value, host Søren Spanner Bach is joined by co-host Per Christensen of Black Swans Exist and guests Lasse Rosendahl, Director of CORC, andAlexia Jacobsen, Head of Innovation at CORC - the Novo Nordisk Foundation CO2 Research Center, headquartered in Aarhus with partner institutions across Europe and the US.
The conversation centres on a deceptively simple question:
what does it actually take to translate CO2 research into real-world impact when the value chain you need doesn't yet exist?
Lasse and Alexia walk through the full journey - from TRL 1 microbe experiments exploring how to transform CO2 into methane, to a 200x scale-up pilot facility at Campus Viborg that is already testing market viability by exploring the sale of carbon credits and offtake products at pilot scale.
A key theme throughout is that the TRL ladder is not linear: scaling up consistently surfaces new fundamental questions, sending research back down before moving forward again. Iteration is the design, not the exception.
The bottleneck in commercializing carbon utilization is less about technology maturity and more about the near-complete absence of governmental verification frameworks for CCU and CCC in Europe - and the missing value chains that spin-outs need to survive.
Alexia also introduces CORC's approach to impact measurement: rather than imposing performance indicators that produce what you measure rather than what you want, the team is developing key value measures in direct dialogue with researchers. And critically, the innovation team's role is to remove the administrative and legal obstacles from the researcher's path - so that scientists can stay focused on the science while still contributing to real-world impact.
⏱️ TIMESTAMPS
01:26 What Is CORC? — Mission, Funding and International Scope
04:11 Why CO₂ Research Matters — And What TRL Actually Means
06:45 TRL in Practice — From Lab-Scale Microbes to Pilot Reactors
10:42 The Real Bottleneck — Value Chains That Don’t Exist Yet
17:13 What Can Industry Do? — Spin-Ins, De-Risking and Ecosystem Building
21:57 Researcher KPIs vs Real-World Impact — How to Navigate Both
25:20 CORC’s Four Mission Streams — Interdisciplinary Design
29:01 Keeping Researchers Mission-Aligned — Annual Meetings and Shared Direction
35:00 What Europe Can Learn from the US — Entrepreneurship and Failure Culture
38:21 Coalition on Advancing Research Assessment — Rethinking Researcher Metrics
41:46 Selling Credits at Pilot Scale — Testing the Market Before It Exists
43:15 Excel ERIC — Sharing Infrastructure Across Europe
45:29 Why Aarhus? — Location, Ecosystem and Production Pipeline
46:41 Impact by 2028 — Technologies Out, Value Chains Built, Knowledge Compounded
50:14 Target Industries and Products — What CORC Is Looking For
💡 QUOTES
"If we are not successful in bringing down atmospheric CO2 levels, it will have consequences — not for the planet, which will survive — but for the way we as humans inhabit the Earth." — Lasse
"If the value chain is not there, we set spin-outs up to fail. That's essentially what we're doing." — Alexia
Ideas for future podcast guests or themes? 💡
We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes.
Feel free to share in a private message or leave a comment below 🙏🏼
(It's also ok to invite yourself 😉)
Call to Action
If this episode sparked your interest:
Share it with someone working in science, startups, or innovation
Follow the miniseries for more conversations with ecosystem builders
E71 #Ecosystem Builders "From Spin-Outs to Spin-Ins: How Incuba Shapes Aarhus' Innovation Ecosystem" with Jacob Doktor Mogensen
Season 1 · Episode 71
Thursday, August 13, 2026 • Duration 58:16
Jacob Doktor Mogensen, CEO of Incuba, joins the show to unpack how Aarhus's science park model turns university research into scaled companies.
The conversation moves from Incuba's problem-first, hands-on approach to acceleration, through real cases like Coana and CrowdStrike/Humio, to the harder question of why Danish companies sell out to international capital - and what "spinning in" corporate innovation could change. Listeners get a grounded look at what actually moves a startup from idea to exit.
(10:49) The Investor Hub: proximity that closes deals
(27:26) Success story: Quana's journey and US sale
(41:39) Defining "spin-in" innovation
(46:14) Spin-in success story: CrowdStrike and Humio
(50:01) Turning company problems into student projects
(55:00) Aarhus' innovation ecosystem over the next 10 years
Guest Bio
Jacob Doktor Mogensen is CEO of Incuba, the Aarhus-based science park connecting university spin-outs, established companies, and investors across three hubs. Before Incuba, he spent fifteen years in Danish innovation clusters and science parks, including time in the food industry.
Resources Mentioned
Incuba (Incuba.dk) — science park hubs at Katrinebjerg, Navitas, and Skejby
E70 #Ecosystem Builders “Center for Biosolutions: DTU Vision and Pathways” with Andreas Worberg
Season 1 · Episode 70
Thursday, August 6, 2026 • Duration 01:11:39
In this podcast episode on turning fragmented world-class research into a connected biosolutions ecosystem, host Søren Spanner Bach is joined by guest Andreas Worberg, the driving force behind the new Center for Biosolutions at DTU (Technical University of Denmark) - a cross-departmental initiative uniting eight departments and close to 2,000 researchers under DTU's non-medical biotechnology efforts.
Andreas shares candid reflections on why DTU, despite ranking as Europe's best engineering university and fifth in the world for biotech, has struggled to make that strength visible and legible to industry, policymakers, and the public - and what the new center is doing to fix it.
Key structural challenges discussed include the internal fragmentation of a large polytechnical university where departments rarely know what their neighbours are working on, a publication-driven incentive structure that pushes researchers toward papers over spin-outs, and years of specialised equipment sitting underused in campus vaults due to legal and liability hurdles around sharing it. Andreas also reflects on the trust-building work required to make collaboration feel like an opportunity rather than a threat to a researcher's own career and turf.
Andreas draws a striking comparison to the arrival of ChatGPT, arguing biotechnology is nearing its own inflection point as AI, quantum computing, and biotech converge - and cautions that businesses investing heavily in AI and quantum while overlooking biotech may be missing where the next wave of disruption actually lands. His closing message: DTU has been playing the long game in biosolutions for years, and now, with a center to make that work visible, Denmark's biosolutions ecosystem is ready to be discovered.
⏱️ TIMESTAMPS
04:26 Why Biology Is the Next Manufacturing Platform
E69 #Ecosystem Builders "Denmark's Biotech Potential: Innovation Gaps, Capital Challenges & National Frameworks" with Morten Engsbye
Episode 69
Thursday, June 25, 2026 • Duration 41:48
In this podcast episode on turning research into societal value, host Søren Spanner Bach is joined by co-host Per Christensen of Black Swans Exist and guest Morten Engsbye, CEO of Danish BIO (Dansk Biotek) - the industry association representing over 190 pharmaceutical and industrial biotech companies in Denmark. Morten shares candid reflections on why Denmark, despite being Europe's #2 nation for per-capita life sciences publications, consistently underperforms at translating that world-class research into new companies - and what it will take to fix it.
Key structural challenges discussed include the cultural gap between academic excellence and entrepreneurial ambition, the scarcity of early-stage capital as late-stage companies attract the lion's share of investment, and Denmark's 42% capital gains tax making biotech investment unattractive compared to property or neighbouring Sweden. In a world premiere, Morten also unveils Danish BIO's proposal for direct cash grants to university departments that successfully spin out companies - a mechanism designed to make innovation a leadership priority at department level, not just an individual pursuit.
Morten also sounds the alarm on Denmark's GDP dependency on a small number of blockbuster drugs - life sciences now accounts for approximately 60% of all Danish GDP growth - and makes a compelling case for unlocking the country's 4.5 trillion DKK in pension fund assets, currently investing just 0.018% into venture compared to 1.9% in the US. His closing message: Denmark is a life sciences nation in every metric that matters. It just hasn't realised it yet.
TIMESTAMP
00:00 Morten Engsbye and Danish BIO
E68 #Ecosystem Builders "Turning Great Science into Green Impact: BRIGHT’s Mission, Model, and European Playbook” with Luuk van der Wielen
Luuk introduces BRIGHT's core mission: helping Europe reduce emissions, strengthen resource autonomy, and build a more resilient industrial base - not through isolated breakthroughs, but through the kind of system-level change that reshapes technology, supply chains, regulation, incentives, and social behavior all at once.
The conversation draws on powerful historical precedents - Brazil's Proálcool biofuel program and Denmark's biogas infrastructure - to illustrate why lasting green transitions are never built on a single "silver bullet" product, but on coordinated, long-term ecosystem thinking.
Luuk also shares how BRIGHT itself is evolving: moving beyond its Biosustain roots and a science-and-startup model toward more open public-private collaboration, scenario-based "reverse design" roadmaps anchored in 2050 goals, and impact-focused KPIs that go well beyond publications and patents.
The episode explores BRIGHT's three strategic focus areas - sustainable materials, microbial and sustainable foods, and zero-emission agriculture - and what it means to build research infrastructure that is measured by real-world outcomes.
Finally, Luuk issues a direct invitation to potential partners and makes a compelling case for deeper European collaboration and a fairer, continent-wide level playing field for biotech innovation.
E67 #Ecosystem Builders "Scaling Health Tech: Funding, Traction & Faster EU Approval" with Jesper Grønbæk
Episode 67
Friday, June 12, 2026 • Duration 35:29
In this podcast episode on turning research into societal value, host Søren is joined by co-host Per Christensen of Black Swans Exist and guest Jesper Grønbæk, CEO and founder of the nonprofit Health Tech Hub Copenhagen (supported by the Danish Industry Foundation and the Novo Nordisk Foundation). Jesper shares key learnings from supporting 100+ health tech startups and scale-ups, as well as collaborating with hospitals, pharma, insurers, and a 200+ investor network - including enabling hospital “speed-dating” access in markets like Germany.
Key pitfalls discussed include solving “nice-to-have” problems instead of top-priority hospital needs, failing to secure an influential key opinion leader early, starting fundraising too late while overlooking non-dilutive “soft money” grants, and lacking commercial traction due to staying overly project-focused. He emphasizes the importance of early investor relationship-building, being selective with investors, and maintaining a strong commercial focus - sometimes even launching below MDR/CE-mark requirements first.
Jesper also introduces the upcoming Health Tech Pathways platform, which uses expert-trained AI to guide EU MDR medical device regulation and improve documentation quality - ultimately reducing the time and cost associated with today’s multi-year EU processes.
TIMESTAMP
00:42 Meet Health Tech Hub
01:47 Ecosystem Connections
02:47 Hospital Access Speed Dating
03:50 Why Jesper Started
05:42 Healthcare Pressure Ahead
E66 #Ecosystem Builders "From excellent research to real-world impact" with Jens Nielsen
Jens reflects on his journey from academic researcher and professor in engineering biology to serial entrepreneur and ecosystem builder. He discusses how his passion for translating science into real-world impact led him to found multiple companies and eventually help build BII as a launchpad for early-stage innovation.
The conversation explores how ecosystems are formed, what makes academic science commercially viable, and why the combination of talent, capital, and institutional support is critical. Jens also explains why Denmark has been uniquely successful in scaling biotech startups and what lessons can be transferred to emerging fields like quantum technology.
A central theme is how scientists can transition into entrepreneurship - not just through training, but through mindset shifts, feedback culture, and selecting the right people with coachability, curiosity, and resilience.
The episode also dives into team dynamics, founder evolution, and why most startup challenges ultimately come down to people rather than technology.
Finally, Jens shares a broader reflection on Europe’s opportunity in deep tech and why researchers must take responsibility for translating their own work into societal impact.
E65 #Ecosystem Builders "Bridging Innovation: From Academia to Life Science Startups" with Søren Spanner Bach & Per Christensen
Episode 65
Wednesday, June 3, 2026 • Duration 08:53
In this miniseries episode of Life Science Talent Talks, hosted by Soren in collaboration with Black Swans Exist, we explore how scientific innovation moves from universities and research hubs into real-world companies.
Soren and Per Christensen (co-founder of Black Swans Exist) discuss the “bridge” between academia and industry - where great ideas are created, but not always scaled - and why talent, execution, and cross-sector collaboration are key to turning research into impactful solutions.
The conversation also touches on Europe’s innovation challenges, the startup ecosystem, and the need for more entrepreneurial courage in science and academia.
Timestamps
00:30 – Meet Per Christensen & his background 01:00 – Purpose of the mini-series: bridging innovation and execution 01:14 – What Black Swans Exist does in the ecosystem 02:15 – The “bridge” between academia and real-world application 02:50 – Gaps in innovation vs. execution 03:00 – Untapped innovation potential within universities 03:35 – Talent, funding, and enabling innovation 04:00 – Why this podcast exists 04:19 – Importance of ecosystem builders & shared perspectives 04:30 – Inspiring entrepreneurship and showcasing role models 05:15 – Breaking silos & sharing actionable learnings 05:42 – What to expect from the conversations in this series 06:00 – Entrepreneurial mindset in academia 06:24 – Innovation and the future economy 06:51 – Are we doing enough in innovation? 07:00 – Europe’s strengths vs. commercialization challenges 07:44 – Regulation vs. innovation discussion08:00 – Driving societal change & the need for innovators08:39 – Closing remarks
E64 #StartupStory "Building Biotech from Scratch: The Immunordic Journey" with Emil Arvedsen & Jannik Faliu
Season 1 · Episode 64
Tuesday, February 24, 2026 • Duration 41:23
In this episode, Emil and Jannik, co-founders of Immunordic share their journey of building a startup in the biotech industry.
They discuss the challenges they faced while developing a technology platform for identifying protein binders using limited resources.
The conversation covers their initial focus on building synthetic libraries and wet lab methods, the pivot to an AI and machine learning-based approach, and the lessons learned from both successes and setbacks.
Key insights include the importance of networking, how to build a lab on a tight budget, and the value of persistence and passion in driving a startup forward. They also outline their current focus and future directions, aiming to provide accessible scientific tools for diagnostics, therapeutics, and academic research.
00:40 Founders' Backgrounds
02:29 Immunordic's Mission and Services
03:32 The Origin Story
06:08 Early Challenges and Lessons
11:17 Building the Lab
18:43 Funding and Resources
20:52 Understanding Through Teaching
21:55 Enrolling and Guiding New Lab Members
22:35 Identifying Student Drives and Aligning Projects
23:40 Challenges and Successes with Student Projects
24:39 The Pivot to In Silico Prediction
25:19 Building Synthetic Libraries and Bio Panning
E63 #Leadership “Future-Ready Leadership In The Era Of AI” with Marcelina Dutkiewicz
Season 1 · Episode 63
Thursday, December 4, 2025 • Duration 52:39
In this conversation, Marcelina outlines a practical roadmap for AI transformation within life sciences organizations, emphasizing that real progress begins with leadership alignment and people-centric change management.
She explains that senior leaders must first gain a foundational understanding of AI—ideally becoming super users—to communicate vision, reduce uncertainty, and guide their teams effectively.
People leaders then play a crucial role in translating strategy into day-to-day meaning for employees, influencing priorities, workflows, and professional development.
Marcelina also highlights the importance of governance, data readiness, and collaboration between C-suite leaders and boards, many of whom acknowledge the need for AI upskilling.
She stresses that successful AI adoption requires tailored training, not generic programs, referencing research that shows customized learning dramatically increases the number of super users and hours saved weekly.
Throughout the discussion, she shares insights from her book It Starts With Vision, including interviews with senior leaders across pharma, data science, IT security, and organizational transformation.
She encourages leaders to begin with curiosity, assess their organization’s current maturity, and use surveys and strategic sparring to design transformations that avoid wasted investment and maximize impact.
Key Topics Covered:
00:32:38 Why messaging from senior leadership and people leaders matters most in AI transformation.
00:34:00 Building the AI roadmap: upskilling senior leaders, creating super users, and enabling informed conversations.
00:35:32 The role of boards in guiding AI strategy and the increasing need for board-level AI literacy.
Coana — Aarhus University spin-out and EU Horizon-funded case study
CrowdStrike / Humio acquisition
Delfinus Venture Capital
InnoFonden, InnoBooster, Horizon Europe funding programs
Startup Aarhus
Aarhus Investor Summit (October 8)
Ideas for future podcast guests or themes? 💡
We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes.
Feel free to share in a private message or leave a comment below 🙏🏼
(It's also ok to invite yourself 😉)
10:11 Why Commercialization Boosts a Researcher's Academic Footprint
28:06 Closing the Non-Medical Biotech Innovation Gap
32:57 Papers vs. Spin-Outs: You Get What You Measure
34:28 The Biosustain Lesson: Freedom Breeds Entrepreneurs
53:00 The Innovation Pillar: Learning From MIT's Playbook
57:06 Student-Driven Startups vs. Top-Down Innovation
💡 QUOTES
"Large diverse universities... have the challenge that often the right hand does not necessarily know what the left hand is doing." — Andreas
Links:
https://biosolutions.dtu.dk/
Guest Bio
Andreas trained as a biologist, with a doctorate in Germany spanning botany and molecular biology. He spent ten years at a large German engineering company, where he helped design, build, and operate large-scale biochemical plants as its first biologist. He joined DTU in 2017, spending eight years at DTU Biosustain, and today also connects non-medical biotech to defense applications through NATO.
Ideas for future podcast guests or themes? 💡
We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes.
02:00 The Translation Gap: World-Class Research, Not Enough Companies
03:00 Why Other Countries Are Better at Spinning Out Science
06:00 World Premiere: Danish BIO's Department-Level Spin-Out Incentive Proposal
09:00 Freedom vs Mandates: Why Incentives Beat Obligations
11:00 Genmab, Myelomatosis & What Biotech Success Really Looks Like
13:00 The GDP Time Bomb: When Patents Expire, Markets Collapse
17:00 The Capital Crisis: $2.1 Billion to Bring a Drug to Market
19:00 A Schizophrenic Capital Market: Late-Stage Flush, Early-Stage Starved
20:00 Where Should the Capital Come From? The Draghi & Letta Reports
21:00 Capital Gains Tax: 42% in Denmark vs 27% in Sweden
23:00 Pension Funds: 4.5 Trillion DKK Doing Very Little for Denmark
24:00 The 100x Gap: US vs European Pension Funds in Venture
26:00 Ferrari vs Denmark: One Fund's Investment Priorities
29:00 Forcing vs Incentivising Pension Funds: The Italian Model
30:00 Why It Should Be a Slam Dunk — Jobs, Patients, Returns
34:00 Denmark as a Life Sciences Nation — and Why Politicians Don't See It
36:00 Call to Action for Academics and Department Leaders
40:00 Brain Drain: How Danish Taxpayer-Funded Research Ends Up in Boston
Quote:
"We pay for the research. They build the company here. Then, because there's no capital market, they leave for Boston — pay their taxes there, create all the jobs there. And we sit back holding the bill."— Morten Engsbye
Ideas for future podcast guests or themes? 💡
We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes.
Feel free to share in a private message or leave a comment below 🙏🏼
(It's also ok to invite yourself 😉)
Call to Action
If this episode sparked your interest:
Share it with someone working in science, startups, or innovation
Follow the miniseries for more conversations with ecosystem builders
⏱️ TIMESTAMP
00:00 Series Kickoff
00:36 Meet Pierre and Black Swans
01:13 Luuk’s Career Journey
04:03 What BRIGHT Does
06:28 Innovation for Green Transition
06:51 Brazil’s Biofuel Lesson
08:52 Systems Change Not Silver Bullets
10:20 BRIGHT’s Origin Story
11:56 From Startups to Partnerships
13:22 Biogas to High Value Proteins
16:04 Key Ingredients for Collaboration
17:42 Sustainable Innovation Office
18:22 Reverse Designing the Roadmap
20:28 Scenario Planning and Outreach
21:37 Tech Plus Policy and Society
22:33 Policy Targets and Autonomy
24:02 Biogas Infrastructure Strategy
26:40 Future Scenarios and Innovations
30:00 Impact Metrics in Academia
34:47 Europe Collaboration and Equity
38:03 Ecosystem Gaps and Level Playing Field
39:48 Bright Partnerships and Missions
💡 Quote:
"Innovation is important in the systems change, but also the regulatory system, the financial system. You don't solve it with one super plastic that comes from BioSolutions. You have to look at the total systems change." - Luuk van der Wielen
Ideas for future podcast guests or themes? 💡
We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes.
Feel free to share in a private message or leave a comment below 🙏🏼
(It's also ok to invite yourself 😉)
Call to Action
If this episode sparked your interest:
Share it with someone working in science, startups, or innovation
Follow the miniseries for more conversations with ecosystem builders
06:23 Mistake One Nice to Have
08:43 Key Opinion Leaders
10:12 Mistake Two Fundraising
10:53 Soft Money and Accelerators
12:14 Choosing Investors Wisely
14:48 Mistake Three Commercial Traction
16:42 Traction Under Regulation
18:18 Consumers Paying for Health Apps
19:14 Who Pays for Health Tech
19:56 Building Health Tech Pathways
21:27 MDR Explained and Risk Classes
22:38 Why EU Approval Takes Longer
23:50 Ideal Users and Early Strategy
24:32 Plain English Plus Compliance
26:56 AI Powered Regulatory Guidance
27:38 Cutting Time with Better Docs
28:31 Ecosystem Wishlist Reimbursement
30:33 Community Call to Collaborate
31:30 Denmark Strengths and Next Steps
Quote:
"Finding a co-founder is like finding a spouse — it's somebody you want to work with for a very long time in a harsh environment." — Jesper
Ideas for future podcast guests or themes? 💡
We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes.
Feel free to share in a private message or leave a comment below 🙏🏼
(It's also ok to invite yourself 😉)
Call to Action
If this episode sparked your interest:
Share it with someone working in science, startups, or innovation
Follow the miniseries for more conversations with ecosystem builders
01:00 Jens Nielsen’s Background - Engineering Biology, Academia & Entrepreneurship
03:00 The Birth of BioInnovation Institute (BII)
06:00 Why Denmark Became a Life Science Startup Leader
07:00 From Life Science to Quantum Ecosystems
12:00 Ingredients of a Strong Deep Tech Ecosystem
21:00 Selecting Scientific Entrepreneurs - Science + Market Fit
30:00 Rethinking Startup Education - From Lectures to Gap Analysis
32:00 Mindset of Scientific Entrepreneurs
35:00 Founder-to-CEO Evolution in Scaling Companies
39:00 Cap Tables, Equity & Managing Founder Expectations
41:00 Investor Dynamics & Founder Role Transitions
48:00 Academic Training as Entrepreneurial Advantage
50:00 Europe vs US in Deep Tech Innovation
💡 Quote:
“You cannot find a better entrepreneur to translate science than the person who actually did the science - because they know it deeply and care about making it matter.” - Jens Nielsen
Ideas for future podcast guests or themes? 💡
We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes.
Feel free to share in a private message or leave a comment below 🙏🏼
(It's also ok to invite yourself 😉)
Call to Action
If this episode sparked your interest:
Share it with someone working in science, startups, or innovation
Follow the miniseries for more conversations with ecosystem builders
Key Takeaways
Innovation often exists in universities - but scaling it requires the right people and structures
Talent acquisition is a critical bottleneck in life science and deep tech startups
Europe has strong research output but struggles with commercialization and execution
Cross-sector collaboration can unlock faster innovation
Inspiration and role models can encourage more people to start companies
Bridging academia and industry is essential for future economic growth
Notable Quotes
“If we inspire just one person to start a company, it’s a success.”
“We need innovators and brave people willing to take risks.”
Call to Action
If this episode sparked your interest:
Share it with someone working in science, startups, or innovation
Follow the miniseries for more conversations with ecosystem builders
26:08 Challenges with Wet Lab Services
27:50 Transitioning to Scalable Solutions
28:37 Adopting In Silico Methods
30:40 Client and Market Reactions to the Pivot
39:10 Future Plans and Collaborations
Ideas for future podcast guests or themes? 💡
We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.
Feel free to share in a private message or leave a comment below 🙏🏼
(It's also ok to invite yourself 😉)
Join Our Life Science Talent Ecosystem
We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn community page.
